相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma
Hephzibah Rani S. Tagaram et al.
GUT (2011)
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
William L. Holland et al.
NATURE MEDICINE (2011)
Bioconjugation of Calcium Phosphosilicate Composite Nanoparticles for Selective Targeting of Human Breast and Pancreatic Cancers In Vivo
Brian M. Barth et al.
ACS NANO (2010)
Metabolism of short-chain ceramide by human cancer cells-Implications for therapeutic approaches
Jacqueline V. Chapman et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Inhibition of NADPH oxidase by glucosylceramide confers chemoresistance
Brian M. Barth et al.
CANCER BIOLOGY & THERAPY (2010)
Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation
Bill X. Wu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2009)
Ceramide Metabolism Determines Glioma Cell Resistance to Chemotherapy
Claudia Alexandra Dumitru et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Lysosomal ceramide mediates gemcitabine-induced death of glioma cells
Claudia A. Dumitru et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Ceramide Regulates Gemcitabine-Induced Senescence and Apoptosis in Human Pancreatic Cancer Cell Lines
David E. Modrak et al.
MOLECULAR CANCER RESEARCH (2009)
Near-Infrared Emitting Fluorophore-Doped Calcium Phosphate Nanoparticles for In Vivo Imaging of Human Breast Cancer
Erhan i. Altinoglu et al.
ACS NANO (2008)
Atypical protein kinase CL expression and aurothiomalate sensitivity in human lung cancer cells
Roderick P. Regala et al.
CANCER RESEARCH (2008)
An efficient, one-pot synthesis of various ceramide 1-phosphates from sphingosine 1-phosphate
Peter Nussbaumer et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2008)
Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development
Melissa A. Tran et al.
CLINICAL CANCER RESEARCH (2008)
Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy
Bret B. Friday et al.
CLINICAL CANCER RESEARCH (2008)
Therapeutic nanoparticles for drug delivery in cancer
Kwangjae Cho et al.
CLINICAL CANCER RESEARCH (2008)
A role for ceramide in driving cancer cell resistance to doxorubicin
Yong-Yu Liu et al.
FASEB JOURNAL (2008)
Multi-functional nanocarriers for targeted delivery of drugs and genes
Lara Jabr-Milane et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Protein kinase C - A target for therapy in pancreatic cancer
Bassel F. El-Rayes et al.
PANCREAS (2008)
BCL-2 functions as an activator of the AKT signaling pathway in pancreatic cancer
Melinda M. Mortenson et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Inhibition of proliferation by omega-3 fatty acids in chemoresistant pancreatic cancer cells
Justin Hering et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer
Harikrishna Devalapally et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Elucidation of the relationship of BNIP3 expression to gemcitabine chemosensitivity and prognosis
Masaharu Ishida et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment
Soukaina Rejiba et al.
CANCER SCIENCE (2007)
Ceramide recruits and activates protein kinase C ζ (PKCζ) within structured membrane microdomains
Todd E. Fox et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Cancer statistics, 2007
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Sphingolipids as modulators of cancer cell death:: Potential therapeutic targets
Bruno Segui et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
In vivo antitumor effect of the mTOR inhibitor CCI-779 and gemcitabine in xenograft models of human pancreatic cancer
D Ito et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Effect of gemcitabine on the expression of a poptosis-related genes in human pancreatic cancer cells
Pei-Hong Jiang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Gemcitabine-mediated apoptosis is associated with increased CD95 surface expression but is not inhibited by DN-FADD in Colo357 pancreatic cancer cells
M Christgen et al.
CANCER LETTERS (2005)
Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma
TC Stover et al.
CLINICAL CANCER RESEARCH (2005)
Overcoming resistance to γ-rays in squamous carcinoma cells by poly-drug elevation of ceramide levels
G Alphonse et al.
ONCOGENE (2004)
siRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity
MS Duxbury et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2004)
Mitogenic and antiapoptotic role of constitutive NF-κB/Rel activity in pancreatic cancer
S Liptay et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death
A Arlt et al.
ONCOGENE (2003)
Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells
T Stover et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)